Items where authors include "Lavery, GG"

Article

Morgan, SA, Gathercole, LL, Hassan-Smith, ZK et al. (3 more authors) (2022) 11β-HSD1 contributes to age-related metabolic decline in male mice. Journal of Endocrinology, 255 (3). pp. 117-129. ISSN 0022-0795

Westgate, CSJ, Markey, K, Mitchell, JL et al. (7 more authors) (2022) Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension. European Journal of Endocrinology, 187 (2). pp. 323-333. ISSN 0804-4643

Morgan, SA, Berryman, DE, List, EO et al. (3 more authors) (2022) Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients. Growth Hormone and IGF Research, 62. 101440. ISSN 1096-6374

Hardy, RS, Botfield, H, Markey, K et al. (16 more authors) (2021) 11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension. Journal of Clinical Endocrinology and Metabolism, 106 (1). pp. 174-187. ISSN 0021-972X

Markey, K, Mitchell, J, Botfield, H et al. (22 more authors) (2020) 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial. Brain Communications, 2 (1). fcz050.

Doig, CL, Fletcher, RS, Morgan, SA et al. (6 more authors) (2017) 11β-HSD1 Modulates the Set Point of Brown Adipose Tissue Response to Glucocorticoids in Male Mice. Endocrinology, 158 (6). pp. 1964-1976. ISSN 0013-7227

Hardy, RS, Doig, CL, Hussain, Z et al. (11 more authors) (2016) 11β-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation. Journal of Pathology, 240 (4). pp. 472-483. ISSN 0022-3417

Larner, DP, Morgan, SA, Gathercole, LL et al. (7 more authors) (2016) Male 11β-HSD1 knockout mice fed trans-fats and fructose are not protected from metabolic syndrome or non-alcoholic fatty liver disease. Endocrinology, 157 (9). pp. 3493-3504. ISSN 0013-7227

Morgan, SA, Hassan-Smith, ZK, Doig, CL et al. (3 more authors) (2016) Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism. Journal of Endocrinology, 229 (3). pp. 277-286. ISSN 0022-0795

Nanus, DE, Filer, AD, Yeo, L et al. (8 more authors) (2015) Differential glucocorticoid metabolism in patients with persistent versus resolving inflammatory arthritis. Arthritis Research and Therapy, 171. 121. ISSN 1478-6354

Doig, CL, Bashir, J, Zielinska, AE et al. (3 more authors) (2014) TNFα-mediated Hsd11b1 binding of NF-κB p65 is associated with suppression of 11β-HSD1 in muscle. Journal of Endocrinology, 220 (3). 389 - 396. ISSN 0022-0795

Lavery, GG, Idkowiak, J, Sherlock, M et al. (12 more authors) (2013) Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profiling. European Journal of Endocrinology, 168 (2). K19 - K26. ISSN 0804-4643

Abrahams, L, Semjonous, NM, Guest, P et al. (4 more authors) (2012) Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11β-HSD1 and H6PDH. Journal of Endocrinology, 214 (3). 367 - 372. ISSN 0022-0795

Morgan, SA, Sherlock, M, Gathercole, LL et al. (12 more authors) (2009) 11β-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid- induced insulin resistance in skeletal muscle. Diabetes, 58 (11). 2506 - 2515. ISSN 0012-1797